Table 2. Dose-limiting toxicity (DLT) according to SMM status.

Total (n = 97)	Without low SMM (n = 55)	Low SMM (n = 42)	P-value
DLT			<0.01
No	49 (89.1%)	27 (64.3%)
Yes	6 (10.9%)	15 (35.7%)
DLT in cisplatin
No	38 (90.5%)	20 (66.7%)	0.01
Yes	4 (9.5%)	10 (33.3%)
DLT in paclitaxel/carboplatin			0.14
No	11 (84.6%)	7 (58.3%)
Yes	2 (15.4%)	5 (41.7%)
Reason of DLT			0.45
Haematopoietic toxicity	6 (100%)	10 (66.7%)
Nephrotoxicity	0	2 (13.3%)
Infection	0	3 (20%)

DLT dose limiting toxicity; SMM skeletal muscle mass; Significance p calculated by Pearson’s chi-squared test